Trajectories of Symptom Severity in Children with Autism: Variability and Turning Points through the Transition to School.


Journal

Journal of autism and developmental disorders
ISSN: 1573-3432
Titre abrégé: J Autism Dev Disord
Pays: United States
ID NLM: 7904301

Informations de publication

Date de publication:
Jan 2022
Historique:
accepted: 22 02 2021
pubmed: 12 3 2021
medline: 8 1 2022
entrez: 11 3 2021
Statut: ppublish

Résumé

This study examined the trajectories of autistic symptom severity in an inception cohort of 187 children with ASD assessed across four time points from diagnosis to age 10. Trajectory groups were derived using multivariate cluster analysis. A two trajectory/cluster solution was selected. Change in trajectory slopes revealed a turning point marked by plateauing in symptom reduction during the period of transition to school (age 6) for one of the two trajectories. Trajectories were labelled: Continuously Improving (27%) and Improving then Plateauing (73% of sample). Children in the two trajectories differed in levels of symptom severity, language, cognitive, and adaptive functioning skills. Study findings can inform the development of more personalized services for children with ASD transitioning into the school system.

Identifiants

pubmed: 33704613
doi: 10.1007/s10803-021-04949-2
pii: 10.1007/s10803-021-04949-2
pmc: PMC8732828
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

392-401

Subventions

Organisme : CIHR
ID : HDF-70333
Pays : Canada
Organisme : Canadian Institutes of Health Research (CA)
ID : FDN 93621
Organisme : Canadian Institutes of Health Research (CA)
ID : FDN 143235
Organisme : CIHR
ID : HDF-70333
Pays : Canada

Informations de copyright

© 2021. The Author(s).

Références

Curr Opin Psychiatry. 2017 Mar;30(2):69-76
pubmed: 28067726
J Child Psychol Psychiatry. 2014 Jan;55(1):49-58
pubmed: 23848399
Annu Rev Clin Psychol. 2015;11:53-70
pubmed: 25581244
Pediatrics. 2012 Nov;130(5):e1278-84
pubmed: 23090336
Autism Res. 2014 Apr;7(2):207-15
pubmed: 24550145
J Autism Dev Disord. 2014 Mar;44(3):546-63
pubmed: 23907710
J Child Psychol Psychiatry. 2017 May;58(5):634-636
pubmed: 28414862
JAMA Psychiatry. 2015 Mar;72(3):276-83
pubmed: 25629657
Ment Retard Dev Disabil Res Rev. 2004;10(4):234-47
pubmed: 15666341
J Autism Dev Disord. 2014 Oct;44(10):2400-12
pubmed: 23143131
J Am Acad Child Adolesc Psychiatry. 2018 Nov;57(11):820-821
pubmed: 30392620
BMJ. 2018 May 21;361:k1674
pubmed: 29784657
J Autism Dev Disord. 2015 May;45(5):1254-70
pubmed: 25344152
JAMA Psychiatry. 2019 Nov 1;76(11):1116-1117
pubmed: 31433453
JAMA Pediatr. 2018 Aug 1;172(8):716-717
pubmed: 29946699
J Autism Dev Disord. 2019 Nov;49(11):4390-4399
pubmed: 31372802
Eval Rev. 2007 Dec;31(6):515-47
pubmed: 17986706
Int J Speech Lang Pathol. 2014 Feb;16(1):1-10
pubmed: 24410017
J Commun Disord. 2015 Mar-Apr;54:2-14
pubmed: 25638464
J Am Acad Child Adolesc Psychiatry. 2018 Nov;57(11):837-848.e2
pubmed: 30392625
Stat Methods Med Res. 2017 Feb;26(1):374-398
pubmed: 25147228
Curr Drug Abuse Rev. 2010 Sep;3(3):189-95
pubmed: 20298174
Assessment. 2020 Dec;27(8):1796-1809
pubmed: 30569744
Autism. 2019 Feb;23(2):306-325
pubmed: 29458258
J Am Acad Child Adolesc Psychiatry. 2012 Jun;51(6):622-31
pubmed: 22632621
Am J Speech Lang Pathol. 2011 Aug;20(3):200-8
pubmed: 21478278
Paediatr Child Health. 2015 Nov-Dec;20(8):e43-7
pubmed: 26744563

Auteurs

Stelios Georgiades (S)

Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1280 Main St. W. - MIP Suite 201A, Hamilton, ON, L8S 4K1, Canada. georgis@mcmaster.ca.

Peter A Tait (PA)

Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1280 Main St. W. - MIP Suite 201A, Hamilton, ON, L8S 4K1, Canada.

Paul D McNicholas (PD)

Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1280 Main St. W. - MIP Suite 201A, Hamilton, ON, L8S 4K1, Canada.

Eric Duku (E)

Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1280 Main St. W. - MIP Suite 201A, Hamilton, ON, L8S 4K1, Canada.

Lonnie Zwaigenbaum (L)

University of Alberta, Edmonton, Canada.

Isabel M Smith (IM)

IWK Health Centre, Dalhousie University, Halifax, Canada.

Teresa Bennett (T)

Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1280 Main St. W. - MIP Suite 201A, Hamilton, ON, L8S 4K1, Canada.

Mayada Elsabbagh (M)

McGill University, Montreal, Canada.

Connor M Kerns (CM)

University of British Columbia, Vancouver, Canada.

Pat Mirenda (P)

University of British Columbia, Vancouver, Canada.

Wendy J Ungar (WJ)

University of Toronto, The Hospital for Sick Children, Toronto, Canada.

Tracy Vaillancourt (T)

University of Ottawa, Ottawa, Canada.

Joanne Volden (J)

University of Alberta, Edmonton, Canada.

Charlotte Waddell (C)

Simon Fraser University, Burnaby, Canada.

Anat Zaidman-Zait (A)

Tel Aviv University, Tel Aviv, Israel.

Stephen Gentles (S)

Department of Psychiatry and Behavioural Neurosciences, McMaster University, 1280 Main St. W. - MIP Suite 201A, Hamilton, ON, L8S 4K1, Canada.

Peter Szatmari (P)

Centre for Addition and Mental Health, Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, The Hospital for Sick Children, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH